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General experimental details 
 
Solvents: Solvents were obtained from an Anhydrous Engineering alumina column-based solvent drying 
system. Tetrahydrofuran was dried further by distillation in bulk from sodium and benzophenone under an 
inert (N2) atmosphere. Methanol was dried over charged 3Å molecular sieves and degassed by freeze-thaw 
cycling. Dry dichloromethane was degassed by freeze-thaw cycling. Dry dimethylformamide was purchased 
from Fluka and used without further purification. [2H2]-Dichloromethane and [2H6]-benzene for NMR studies 
was purchased from Cambridge Isotope Laboratories and distilled in small quantities from molecular sieves 
(3Å) under an inert (N2) atmosphere immediately prior to use. 
 
Materials: All starting materials and reagents were obtained from commercial sources (Aldrich, Lancaster, 
Alfa Aesar, Fluka, Acros, Strem, TCI Chemicals and Avacado) unless otherwise stated. 
 
Techniques: All air-sensitive manipulations were conducted under an inert (N2) atmosphere using standard 
Schlenk-line techniques. Catalytic runs were performed in a Radleys Carousel reactor under an inert (N2) 
atmosphere. Samples for GC or GC-MS analysis were obtained by removal of a small quantity (≈ 20 µL) of 
the reaction mixture by gas-tight syringe, followed by quenching with triphenylphosphine. Each sample was 
then filtered through a silica plug into a GC vial. Selected samples were re-run to make sure that the 
reactions had stopped turning over after quenching. 
 
Analysis: Gas Chromatography: GC samples were analysed on Hewlett Packard HP5890 (GC) with flame 
ionisation detector (detector gases – hydrogen at 30 cm3 min-1, air at 400 cm3 min-1, helium at 20 cm3 min-1; 
split ratio 1:50; carrier gas – helium at 1 cm3 min-1; column – Alltech EC™, 30 m x 0.25 mm ID, 0.25 µm film 
thickness) and Varian Saturn 2200  (GC/MS). 
 
Column Chromatography: BDH silica gel 60-120 mesh. Thin Layer Chromatography: 0.25mm, Merck silica 
gel 60 F254 developed with 2% KMnO4. 
 
NMR:  NMR spectra were obtained on Varian 400, Lambda 300, JEOL ECP300 and ECP400 instruments 
utilising the 2H-signal from the solvent as the frequency lock. 1H and 13C{1H} NMR spectra were referenced 
internally to the solvent, or to TMS (0 ppm) for samples dissolved in CDCl3. The following abbreviations are 
used for NMR signal assignments: s (singlet), d (doublet), t (triplet), q (quartet), qu (quintet), sx (sextet), sep 
(septet), m (multiplet), br (broad). 
 
Infrared (solid or neat liquid phase): Perkin Elmer Spectrum One. The position of bands are quoted as 
wavenumbers (cm-1) and described using the following abbreviations: weak (w), strong (s) and broad (br). 
 
Mass Spectrometry: High-resolution mass spectra (HRMS) [Positive Ion EI and CI or Electrospray (ES)] 
were obtained at the Mass Spectrometry Laboratory in the University of Bristol School of Chemistry. 
 

















n-BuLi (16.0 cm3, 39.8 mmol, 2.5M in hexane) was added dropwise to a solution of decyne (5.0 cm3, 36.2 
mmol) in THF (50 cm3) at -78 oC. The solution was stirred for 20 minutes and deuterium oxide (1.0 cm3, 52.0 
mmol) was added via syringe. The solution was allowed to reach room temperature and the mixture was 
extracted with diethyl ether (3 × 30 cm3). The combined organic layers were washed with aqueous 0.1M HCl 
(30 cm3) and brine (30 cm3), dried over anhydrous MgSO4, filtered and concentrated under reduced pressure 
to afford 1-[2H1]-1-decyne as a colourless oil (4.6 g, 91 %); 1H NMR (400 MHz, CDCl3, 23 oC, TMS) δ = 2.18 
(t, 3J(H,H) = 6.8 Hz, 2H, C(3)-H), 1.92 (t, 0.03H, residual C(1)-H), 1.51 (qu, 2H, 3J(H,H) = 6.8 Hz, C(4)-H), 
1.40-1.28 (br m, 10H, C(5-9)-H), 0.88 (t, 3J(H,H) = 6.2 Hz, 3H, C(10)-H); [2H1]-incorporation: > 97% (alkyne); 
13C NMR (100 MHz, CDCl3, 23 oC) δ = 84.3 (t, 2J(C,D) = 7.3 Hz, C(2)), 67.8 (t, 1J(C,D) = 37.4 Hz, C(1)), 31.7, 

















1-[2H1]-Dec-1-yne (4.0 g, 28.8 mmol) was added to a suspension of Schwarz reagent (9.65 g, 37.4 mmol) in 
DCM (20 cm3) at -10 oC. The mixture was stirred for 20 minutes to give a bright yellow transparent solution. 
Deuterium oxide (5.0 cm3) was then added and the mixture was stirred vigorously for a further 10 minutes at 
room temperature. The organic layer was separated and passed through a short plug (ca. 5cm) of silica-gel. 
The solution was concentrated under reduced pressure to afford a pale yellow oil. Isolation by Kogelröhr 
distillation (180 oC, 760 torr) afforded 1-[2H]2-dec-1ene as a colourless oil (3.3 g, 82%); 1H NMR (400 MHz, 
CDCl3, 23 oC, TMS) δ = 5.80 (m, 1H, C(2)-H), 4.92-4.88 (m, 0.02H, residual C(1)-H), 2.07 (dt, 2H, 3J(H-H) = 
7.5, 3J(H-H) = 6.7 Hz, C(3)-H), 1.31 (br m, 12H, C(4,5,6,7,8,9)-H), 0.92 (t, 3J(H,H) = 7.2 Hz, 3H, C(10)-H); 
[2H2]-incorporation: > 98%; 13C NMR (100 MHz, CDCl3, 23 oC) δ = 139.0 (C(2)), 113.8 (quint, 1J(C,D) = 23.4 
Hz, C(1)), 33.7 (C(3)), 32.2 (C(8)), 29.5, 29.3, 29.2, 29.1 (C(4-7)), 22.8 (C(9)), 14.0 (C(10)). Data is 


















Bromine was added dropwise to a stirred solution of dec-1-ene (100 mg, 0.72 mmol) in DCM (10 cm3) until a 
dark red colour persisted. The solution was then concentrated under vacuum to afford 1,2-dibromodecane as 
a pale yellow oil (210 mg, 97%); 1H NMR (300 MHz, CDCl3, 23 oC, TMS): δ = 4.17 (m, 1H, C(2)-H), 3.84 (dd, 
3J(H,H) = 5.0, 3J(H,H) = 10.3 Hz, 1H, C(1)-H), 3.62 (t, 3J(H,H) = 10.3 Hz, 1H, C(1)-H), 1.81-1.71 (m, 2H, 
C(3)-H), 1.37-1.19 (br m, 12H, C(4-9)-H), 0.88 (t, 3J(H,H) = 6.4 Hz, 3H, C(10)-H); 13C NMR (75 MHz, CDCl3, 
23 oC) δ = 53.3 (C(2)), 36.4 (C(1)), 36.1 (C(3)), 31.9 (C(8)), 29.5, 29.3, 28.9, 26.8 (C(4-7)), 22.8 (C(9)), 14.2 
(C(10)); IR (neat): υ = 2927 (w), 2850, 1738 (w), 1366 (s), 1228 (w) cm-1; MS (EI) m/z (%): 299 [MH] + (9), 



















Bromine was added dropwise to a stirred solution of [2H]2-1-decene (100 mg, 0.71 mmol) in DCM (10 cm3) 
until a dark red colour persisted. The solution was then concentrated under vacuum to afford 1,1-[2H]-1,2-
dibromodecane as a pale yellow oil (208 mg, 96%); 1H NMR (300 MHz, CDCl3, 23 oC, TMS): δ = 4.16 (br d, 
3J(H,H) = 8.9 Hz, 1H, C(2)-H), 3.84 (m, 0.03H, residual C(1)-H), 3.62 (m, 0.03H, C(1)-H), 1.83-1.71 (m, 2H, 
C(3)-H), 1.38-1.19 (br m, 12H, C(4-9)-H), 0.88 (t, 3J(H,H) = 6.6 Hz, 3H, C(10)-H); [2H]2-incorporation: > 97%; 
13C NMR (75 MHz, CDCl3, 23 oC) δ = 53.3 (C(2)), 36.3 (qu, 1J(C,D) = 22.5 Hz, C(1)), 36.0 (C(3)), 31.9 (C(8)), 
29.5, 29.4, 28.9, 26.7 (C(4-7)), 22.8 (C(9)), 14.2 (C(10)); IR (neat): υ = 2929 (w), 1739 (w), 1372 (s), 1217 














The compound was prepared in situ by RCM of the corresponding enyne [2H7]-1a 
1H NMR (400 MHz, CDCl3, 23 oC, TMS)  δ = 6.45 (m, 0.03H, C(6)-H), 5.56 (d, 3J(H,H) = 1.8 Hz, 1H, C(4)-H), 
5.09 (d, 2J(H,H) = 2.5 Hz, 2H, C(7)-H), 3.73 (s, 0.01H, residual C(4)-(CO2Me)2), 3.18 (d, 3J(H,H) = 1.8 Hz, 
2H, C(5)-H), 3.14 (s, 2H, C(2)-H); [2H]-incorporation: > 97% (C(6)-H), > 99% (malonate methyl groups); 13C 
NMR (100 MHz, CDCl3, 23 oC)  δ = 172.5 (C(2 × C=O)), 139.9 (C(3)), 132.0 (t, 1J(C,D) = 23.4 Hz, C(6)), 
126.8 (C(4)), 115.0 (C(7)), 58.6 (C(1)), 52.2 (septet, 1J(C,D) = 22.6 Hz, C(2 × CD3)), 40.9 (C(5)), 39.2 (C(2)).  
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1H NMR (300 MHz, CDCl3, 23 oC, TMS) δ = 6.14 (d, 3J(H,H)trans = 15.6 Hz, 1H, C(1’)-H), 5.56 (dt, 3J(H,H)trans 
= 15.6, 3J(H,H) = 6.9 Hz, 1H, C(2’)-H), 5.40 (s, 1H, C(4)-H), 3.72 (s, 6H, C(1)-(CO2Me)2-H), 3.12 (br s, 2H, 
C(5)-H), 3.09 (br s, 2H, C(2)-H), 2.05 (dt, 3J(H,H) = 6.9, 3J(H,H) = 7.1 Hz, 2H, C(3’)-H), 1.39-1.36 (m, 2H, 
C(4’)-H), 0.87 (t, 3J(H,H) = 6.9 Hz, 3H, C(5’)-H); 13C NMR (75 MHz, CDCl3, 23 oC) δ = 172.7 (C(2 × C=O)), 
139.7 (C(3)), 132.6 (C(2’)), 125.9 (C(4)), 123.9 (C(1’)), 60.2 (C(1)), 58.8 (C(5)), 52.9 (C(2 × CH3)), 40.8 
(C(2)), 39.9 (C(3’)), 22.5 (C(4’)), 13.8 (C(5’)); IR (neat): υ = 2930 (w), 1732 (s, C=O), 1251 (s) cm-1; MS (EI) 
m/z (%): 253 [MH]+
 




















1H NMR (300 MHz, CDCl3, 23 oC, TMS)  δ = 6.15 (d, 3J(H,H)trans = 15.8 Hz, 1H, C(1’)-H), 5.56 (dt, 3J(H,H)trans 
= 15.8, 3J(H,H) = 6.8 Hz, 1H, C(2’)-H), 5.43 (s, 1H, C(4)-H), 3.75 (s, 6H, C(1)-(CO2Me)2-H), 3.13 (br s, 2H, 
C(5)-H), 3.10 (br s, 2H, C(2)-H), 2.09 (dt, 3J(H,H) = 6.8, 3J(H,H) = 6.9 Hz, 2H, C(3’)-H), 1.31-1.24 (m, 4H, 
C(4’,5’)-H), 0.87 (t, 3J(H,H) = 6.9 Hz, 3H, C(6’)-H); 13C NMR (75 MHz, CDCl3, 23 oC)  δ = 172.8 (C(2 × C=O)), 
140.1 (C(3)), 133.1 (C(2’)), 126.1 (C(4)), 123.9 (C(1’)), 60.4 (C(1)), 58.7 (C(5)), 52.8 (C(2 × CH3)), 41.0 
(C(2)), 39.8 (C(3’)), 32.0 (C(4’)), 21.2 (C(5’)), 14.1 (C(6’)); IR (neat): υ = 2956 (w), 1733 (s, C=O), 1250 (s) 
cm-1; MS (EI) m/z (%): 266 [MH]+
 



















1H NMR (300 MHz, CDCl3, 23 oC, TMS)  δ = 6.18 (d, 3J(H,H)trans = 15.6 Hz, 1H, C(1’)-H), 5.58 (dt, 3J(H,H)trans 
= 15.6, 3J(H,H) = 6.8 Hz, 1H, C(2’)-H), 5.40 (s, 1H, C(4)-H), 3.74 (s, 6H, C(1)-(CO2Me)2-H), 3.14 (br s, 2H, 
C(5)-H), 3.10 (br s, 2H, C(2)-H), 2.08 (dt, 3J(H,H) = 6.8, 3J(H,H) = 7.1 Hz, 2H, C(3’)-H), 1.38-1.26 (m, 8H, 
C(4’,5’,6’,7’)-H), 0.90 (t, 3J(H,H) = 6.9 Hz, 3H, C(8’)-H); 13C NMR (75 MHz, CDCl3, 23 oC)  δ = 172.6 (C(2 × 
C=O)), 139.2 (C(3)), 132.4 (C(2’)), 125.8 (C(4)), 123.8 (C(1’)), 60.1 (C(1)), 58.7 (C(5)), 52.9 (C(2 × CH3)), 
40.9 (C(2)), 39.3 (C(3’)), 33.9, 30.5, 29.3 (C(4’,5’,6’)), 22.7 (C(7’)), 14.1 (C(8’)); IR (neat): υ = 2930 (w), 1734 
(s, C=O), 1250 (s) cm-1; MS (EI) m/z (%): 295 [MH]+
 





















1H NMR (300 MHz, CDCl3, 23 oC, TMS)  δ = 6.17 (d, 3J(H,H)trans = 15.6 Hz, 1H, C(1’)-H), 5.56 (dt, 3J(H,H)trans 
= 15.6, 3J(H,H) = 6.8 Hz, 1H, C(2’)-H), 5.43 (s, 1H, C(4)-H), 3.75 (s, 6H, C(1)-(CO2Me)2-H), 3.12 (br s, 2H, 
C(5)-H), 3.09 (br s, 2H, C(2)-H), 2.09 (dt, 3J(H,H) = 6.8, 3J(H,H) = 7.1 Hz, 2H, C(3’)-H), 1.32-1.25 (m, 12H, 
C(4’,5’,6’,7’,8’,9’)-H), 0.89 (t, 3J(H,H) = 7.3 Hz, 3H, C(10’)-H); 13C NMR (75 MHz, CDCl3, 23 oC) δ = 172.7 
(C(2 × C=O)), 139.8 (C(3)), 132.9 (C(2’)), 125.7 (C(4)), 123.8 (C(1’)), 60.5 (C(1)), 58.8 (C(5)), 53.0 (C(2 × 
CH3)), 40.9 (C(2)), 40.0 (C(3’)), 32.9, 32.0, 29.6, 29.4 (C(4’,5’,6’,7’,8’)), 22.8 (C(9’)), 14.2 (C(10’)); IR (neat): 
υ = 2929 (w), 1732 (s, C=O), 1252 (s) cm-1; MS (CI) m/z (%): 323 [MH]+
 
(51), 291 (14), 262 (100); HRMS 



















1H NMR (300 MHz, CDCl3, 23 oC, TMS) δ = 6.15 (d, 3J(H,H)trans = 15.6 Hz, 1H, C(1’)-H), 5.59 (dt, 3J(H,H)trans 
= 15.6, 3J(H,H) = 6.8 Hz, 1H, C(2’)-H), 5.40 (s, 1H, C(4)-H), 3.71 (s, 6H, C(1)-(CO2Me)2-H), 3.08 (br s, 2H, 
C(5)-H), 3.04 (br s, 2H, C(2)-H), 2.01 (dt, 3J(H,H) = 6.8, 3J(H,H) = 7.1 Hz, 2H, C(3’)-H), 1.40-1.20 (m, 20H, 
C(4’-13’)-H), 0.88 (t, 3J(H,H) = 6.9 Hz, 3H, C(14’)-H); 13C NMR (75 MHz, CDCl3, 23 oC) δ = 172.5 (C(2 × 
C=O)), 139.7 (C(3)), 132.9 (C(2’)), 125.7 (C(4)), 123.8 (C(1’)), 60.4 (C(1)), 58.6 (C(5)), 52.7 (C(2 × CH3)), 
40.8 (C(2)), 39.8 (C(3’)), 32.9, 31.0, 29.8, 29.6, 29.4, 29.3, 27.9 (C(4’-12’)), 22.8 (C(13’)), 14.0 (C(14’)); IR 
(neat): υ = 2931 (w), 1732 (s, C=O), 1267 (s) cm-1; MS (EI) m/z (%): 379 [MH]+
 
(100), 319 (47), 111 (64), 




379.2848, found 379.2842.  
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2 Cl  
 
Allyl chloride (462 mg, 6.1 mmol) was added to a stirred solution of Grubbs Generation I, (benzylidene 
complex, 3a) (500 mg, 0.61 mmol) in DCM (10 cm3) at -40 oC. The reaction was stirred under an atmosphere 
of nitrogen for 20 minutes. The solvent was then removed under vacuum to afford a mixture of desired 
product, 3b and starting material, 3a as a burgundy powder (335 mg, 70%, 85:15 – Product, 3b: Starting 
Material, 3a); This was the most favourable ratio attainable with further cycles resulting in increased 
decomposition; 1H NMR (300 MHz, CD2Cl2, 23 oC) δ = 18.75 (t, 3J(H,H) = 4.8 Hz, 1H, C(1)-H), 4.43 (d, 
3J(H,H) = 4.8 Hz, C(2)-H), 2.62-2.44, 1.91-1.63, 1.59-1.38 and 1.34-1.13 (all m, P(C6H11)3-H); 31P NMR (300 



















A solution of Grubbs Generation I, (benzylidene complex) (500 mg, 0.61 mmol) in DCM (10 cm3) was added 
to a solution of 1-hexene (510 mg, 6.1 mmol) in DCM (5 cm3) and stirred under an atmosphere of nitrogen 
for 20 minutes at room temperature. The solvent was then removed under vacuum. This procedure was 
repeated until all starting material was consumed (as indicated by 31P NMR). The resultant residue was 
washed with cold methanol (3 × 5 cm3) and dried under vacuum for several hours. 3c was obtained as a 
deep purple solid (462 mg, 94%); 1H NMR (300 MHz, CD2Cl2, 23 oC) δ = 19.23 (t, 3J(H,H) = 5.1 Hz, 1H, C(1)-
H), 2.73 (dt, 3J(H,H) = 5.1, 3J(H,H) = 5.2 Hz, C(2)-H), 2.60-2.42, 1.93-1.38, 1.35-1.14 and 0.97-0.85 (all m, 
C(3,4,5)-H and P(C6H11)3-H); 31P NMR (300 MHz, CD2Cl2, 23 oC)δ = 36.10 (s, PCy3); MS (ESI) m/z: 767 [M-




767.4148, found 767.4150. 0). Data is consistent  that 






















A solution of Grubbs Generation I (benzylidene complex) (500 mg, 0.61 mmol) in DCM (10 cm3) was added 
to a solution of allyl malonate (1.1 g, 6.1 mmol) in DCM (5 cm3) and stirred under an atmosphere of nitrogen 
for 20 minutes at room temperature. The solvent was then removed under vacuum. This procedure was 
repeated until all starting material was consumed (as indicated by 31P NMR). The resultant residue was 
washed with cold methanol (3 × 5 cm3) and dried under vacuum for several hours. 3d was obtained as deep 
purple solid (462 mg, 94%); 1H NMR (300 MHz, CD2Cl2, 23 oC) δ = 18.98 (t, 3J(H,H) = 5.1 Hz, 1H, C(1)-H), 
3.74 (s, 6H, C(3)-(CO2Me)2-H), 3.26 (t, 3J(H,H) = 7.0 Hz, 1H, C(3)-H), 2.52 (m, 2H, C(2)-H), 2.59-2.44, 1.93-
1.44 and 1.33-1.14 (all m, P(C6H11)3-H); 13C NMR (125 MHz, CD2Cl2, 23 oC) δ = 306.8 (C(1)), 168.9 (2 × 
C=O), 56.3 (C(2)), 51.3 (C(2 × CH3)), 49.3 (C(3)), 31.8 (pseudo t, 2J(C,P) = 10.0 Hz, C(1’)), 29.4 (C(3’,5’)), 
27.8 (pseudo t, 3J(C,P) = 4.5 Hz, C(2’,6’)), 26.9 (C(4’)); 31P NMR (300 MHz, CD2Cl2, 23 oC) δ = 36.90 (s, 
PCy3); IR (neat): υ = 2929 (w), 2850, 1732 (s, C=O), 1440 (s), 1266 (w) cm-1; MS (ESI) m/z: 855 [M-Cl]+;
 




855.3945, found 855.3961; Anal. Calcd for 





Reaction employing Grubbs Generation I in conjunction with [2H2]-decene, example 
of analysis by GC and GC-MS (as shown in Scheme 4 in communication) 
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(b) [2H7]-reference products, [2H7]-2a (m/z 217) 
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Sample 2: Bromine was added drop-wise to the second sample until its deep red colour persisted upon 
shaking. 1-Pentene was then added to quench any excess bromine to afford a once again colourless 
solution. This second sample was then also analysed by GC/MS: 
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Kinetics of alkene exchange between ruthenium alkylidenes 3b, 3c and 3d, by 31P 




















Typical procedure: a solution of ruthenium alkylidene A (0.024 mmol in DCM (0.4 cm3) was added via gas-
tight syringe to a solution of alkene (0.024 mmol) in a mixture of DCM (0.3 cm3) and d2-DCM (0.1 cm3), in a 
5 mm diameter NMR tube under nitrogen. The tube was sealed with a Young's valve. The resulting 0.8 cm3 
sample had [A]0 = 30 mM and [alkene]0 = 30 mM. Equilibration was monitored by 31P NMR analysis of the 
signals for the PCy3 in alkylidenes A and B. An example NMR spectrum is shown below where 
RuCl2(=CHCH2C(CO2Me)2)(PCy3) (3d = A) was employed in conjunction with 1-hexene to give 




Data were collected until > 80 % equilibrium had been obtained and then analysed by automated iterative 
fitting to a genuine bimolecular equilibrium: {A + alkene-b <—> B + alkene-a}, thus extracting kex(forward), 
kex(backward) and Kex for the pseudo bimolecular equilibrium which will also include a Cy3P dissociation pre-
equilibrium. The resulting datapoints and fits are shown below. 
31P{1H} NMR 







Kinetics of RCM of enyne 1a using alkene co-catalysts 
 
All reactions were conducted according to the following general procedure: a solution of 1a (0.24 mmol, 
0.06M overall), internal standard (dodecane) and additive (0.006 mmol, 0.0015M overall, 2.5 mol% to 1.2 
mmol, 0.3M overall, 500 mol%) in dry DCM (2 cm3) was stirred at room temperature under nitrogen. Additive 
solutions were generally taken from pre-prepared stock solutions (e.g. for a 5 mol% loading (0.003M), a 100 
µL aliquot was taken from a 10 cm3, 0.12M solution). A solution of catalyst (0.012 mmol, 0.003 M, 5 mol%) in 
dry DCM (2 cm3) was then added via gas-tight syringe. Reactions were then sampled  (≈ 20 µL aliquots via 
50 µL syringe) and samples quenched by passing the solution through a pad of silica-gel impregnated with a 
large excess of triphenylphosphine into a vial ready for analysis by GC analysis using dodecane as an 
internal integration standard. In some cases, e.g. allyl alcohol, allyl cyanide, the additive had a distinct 
inhibitory effect and the kinetics were not analysed. However, in general 1a was found to approximately 
decay according to a simple pseudo first-order rate law and thus kOBS values were extracted by linear 
regression of plots of ln(1/x1a)  - where x1a is the mol-fraction of 1a remaining and {(x1a)t=0 = 1} – versus time 
(t). The value of t0 is not the time at which the catalyst was added and thus there is a positive y-axis intercept 
in the plot. Due to progressive catalyst deactivation and cross-metathesis, rates deviated significantly from 
apparent non-first order behaviour above a certain threshold of conversion, depending on the additive being 
used. These thresholds ranged from ca. 25 % (no additive) to > 85% and data above the thresholds were 
excluded from the linear regression analysis. Representative decays and associated linear regressions of 
















IMPORTANT: the reaction kinetics (kOBS) were found to vary by up to 2-fold between different batches of 3a. 
Thus single batches of 3a were used for each series of comparisons (e.g. for comparing alkene length, or for 
the effect of [alkene]) together with a control reaction (no additive). In all of the tabulated data below, rate 
constants (kOBS) should not be transposed between tables, but only within tables , to ensure that data from 
the same batch of catalyst is being compared. Where different batches of catalyst are employed within the 
same table, this is indicated.  There was no obvious difference between the batches in terms of physical 
appearance, solution phase colour or 31P{1H} NMR spectrum (clean singlet in all cases). 
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Effect of simple alk-1-enes on RCM of 1a  - maximum rate acceleration (kSAT / k0) and RCM-CM 
 
Reactions with n-alk-1-enes (CxH2x) where x = 2, 5, 6, 8, 10, 12, 14, 18 were run with 500 mol% alkene, to 
ensure saturation, vide infra, and the kOBS (= kSAT) value compared with  kOBS (= k0) obtained in control 




CxH2x x = kOBS (= kSAT) kSAT/k0 [7a]/{[2a]+[7a]}60 (%) 
 (× 104 / sec) 
_______________________________________________________________________________ 
none 1.51 1.00 -- 
5 8.5 5.6 8.8 
6 8.4 5.6 9.9 
8 5.0 3.3 12.6 
10 3.8 2.5 18.9 
12 5.3 3.5 6.5 
14 4.8 3.2 23.5 
18 5.5 3.6 26.9 
none 1.1S6 1.00 -- 




The rate ratios (kSAT / k0) which correspond to the maxiamum acceleration under these conditions were 
analysed as a function of x (graph A below). In all cases (except the control reaction) The conversion of 1a 
was > 85% after 60 minutes and the proportion of RCM-CM product ([7a]/{[2a]+[7a]})60 (%) at this point was 
analysed as a function of x; graph B (the data for dodecane appears anomalous, but was consistently low 
throughout the run, and is omitted from the plot). 
 
 





Effect of simple n-alk-1-enes on RCM of 1a  - order in alkene CxH2x where x = 6, 10, 14 
 
 
Reactions with n-alk-1-enes (CxH2x) where x = 6, 10 and 14 were run with 0 to 500 mol% alkene and the kOBS 
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